Navigation Links
Otho S.A. Sprague Memorial Institute awards Rush nearly $125,000 for new patient-safety project
Date:2/22/2008

The Otho S.A. Sprague Memorial Institute has awarded Rush University Medical Center a $124,633 grant to support a first-of-its-kind patient-safety project. The pilot program will use Rushs mediation program to foster the development of interventions to avoid or modify activities and procedures that may have adverse effects on patients. This innovative program has the potential to serve as a model for similar mediation programs throughout Chicago and the nation.

Mediation is a voluntary process in which a trained mediator serves as a neutral guide to help resolve problems that otherwise may go to court. In Rushs mediation and patient-safety project, the mediation process is used to amicably resolve disputes and then moves to ensure that corrective action is taken to prevent avoidable adverse events in the future.

Rush envisions a leading-edge approach to reducing future medical malpractice actions. Under The Otho S.A. Sprague Memorial Institute grant, patient safety officers will become an integral part of the Rush Mediation Program, offering clinical strategies to reduce the possibility that similar incidents will occur, said Max D. Brown, JD, vice president and general counsel of the Office of Legal Affairs.

The mediation team, led by Brown and Judge Jerome Lerner, mediation consultant in the Office of Legal Affairs, will review a sampling of cases. They will select those with critical safety issues and that best represent preventable harms while holding promise to effect lasting change on patient safety. A team will conduct a root cause analysis of those cases. Robert A. McNutt, MD, chief of the Section of Medical Informatics and Patient Safety, will serve as medical advisor on evidence and study designs for the patient safety projects that emanate from these cases. The team will disseminate its findings to senior executives within Rush and later to Chicagos medical and legal communities. The grants internal and external educational
'/>"/>

Contact: Mary Ann Schultz
mary_ann_schultz@rush.edu
312-942-7816
Rush University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Otho S.A. Sprague Memorial Institute awards Rush $230,000 for childhood obesity prevention
2. MemorialCare Medical Centers CEO Barry Arbuckle Elected Chair of California Hospital Association
3. Sharp Memorial Hospital Achieves Highest Honor for Nursing Excellence
4. Northwestern Memorial HealthCare and Northwestern Memorial Foundation Elect New Members to Board of Directors
5. Northwestern Memorials Heart Center Pioneers Minimally Invasive Surgery That Corrects Irregular Heart Beat
6. Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery
7. ...And the Grand Prize Goes to... Lockport Memorial Hospital, Winner of Siemens National Win an MRI Contest
8. GREENGUARD 2008 Memorial Fellowship Winners Will Examine Design
9. A Fort Worth Couple Sues Huguley Memorial Medical Center
10. Pennsylvania Invests $13.4 Million to Kick Off Butler Memorial Hospital Expansion
11. Dr. Lewis Drusin receives American College of Physicians James D. Bruce Memorial Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...of local dance students will dance to raise money ...OLIS, Jan. 8 , , , WHO: ...l show off their talent in the 3rd annual Dance, ... Dance Arts Centre. The, event wi...r., Participants raise money thr...
(Date:1/8/2009)...ounced Acquisition in 2009 Continues Growth Trend ...-FirstCall/ -- IPC The Hospitalist Company, Inc. (...hysician group practice company, announced today t...dwest Acute Care Consultants, Inc. (MACC) in St. L...ed expansion in the St. Louis market, where IPC ha...
(Date:1/8/2009)...N, Jan. 8 The Pew Chari...s been named director, chemical and food safety pr...program. Olson, who was formerly deputy staff dire...n Environment and Public Works, brings nearly 25 y...sumer advocacy to Pew. , , "We are excited to ...
(Date:1/8/2009)...a., Jan. 8 Cephalon, In...aldino, Jr., Ph.D., Chairman and CEO will present...eld on January 13, 2009 in San Francisco, CA at ap... Time). The presentation will be webcast live on t...site. , , The webcast will be archived for one...
Breaking Medicine News(10 mins):Health News:Dance With Courage to Benefit Camp Courage 2Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3
...ns, polio is a disease from the past, a successful...oks.// But around the globe it’s a different story...s arguably the greatest-ever act in the name of th...f coordinated effort by millions of healthcare wor...
...the Johns Hopkins Bloomberg School of Public Healt...w test for detecting //the malaria parasite in hum...t for determining treatment, the method could pote...demiological studies where large-scale malaria scr...
...stino SJ, a Jesuit priest, well-known for his care...way on Monday at the age of 80. He was the MD, fou...ome, a centre for abandoned HIV-positive children....f People for Peace in Africa, paid the following t...
...dical workforce should be a key component of healt...the Victorian state//election, according to the Au...rkforce problems do not end with the opening of ne...’ said AMSA President, Teresa Cosgriff. ‘These stu...
Other Medicine News:Health News:Global Polio Eradication: A Campaign to Vaccinate Every Child on the Planet 2Health News:Safer Method for Large-Scale Malaria Screening Developed 2Health News:Prioritise Doctor Training in Election Health Promises: AMSA 2
(Date:1/8/2009)... treated at the initial dose in an ongoing Phase I... decline after three days , , Conference Call T...wswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. ... first cohort of an ongoing Phase Ib clinical tria...leoside polymerase inhibitor. ANA598 was very wel...
(Date:1/7/2009)...K, Md., Jan. 7 ImQuest Life Scienc... IND application to the Food and Drug Administrati...d pyrimidinedione HIV inhibitor IQP-0410. ImQuest ...e first quarter of 2009. IQP-0410 is a novel small... a nonnucleoside reverse transcriptase inhibitor (...
(Date:1/6/2009)...Expands on Successful Results from prior U.S., U.K...swire/ -- Vital Therapies, Inc. (VTI), a developme...nounced patient enrollment has begun for a randomi...ial that will study the Extracorporeal Liver Assis...cute Liver Failure (ALF) under three protocols. Th...
(Date:1/6/2009)...E, Md., Jan. 6 Sequella... focused on diseases of epidemic potential, announ...the treatment of tuberculosis (TB), was the first ...inical program contract to Dynport Vaccine Company...arded by the National Institute of Allergy and Inf...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Aspreva receives final court approval for acquisition by Galenica 8509 1Aspreva receives final court approval for acquisition by Galenica 8509 2Aspreva receives final court approval for acquisition by Galenica 8509 3Aspreva receives final court approval for acquisition by Galenica 8509 4Alsius Corporation Announces Program for Early Exercise of Warrants 8507 1Alsius Corporation Announces Program for Early Exercise of Warrants 8507 2Alsius Corporation Announces Program for Early Exercise of Warrants 8507 3Alsius Corporation Announces Program for Early Exercise of Warrants 8507 4New neuroimaging study identifies brain signature for cigarette cravings 8506 1New neuroimaging study identifies brain signature for cigarette cravings 8506 2Cumberland Pharmaceuticals Announces Appointments 8504 1Cumberland Pharmaceuticals Announces Appointments 8504 2
...SCO confirm safety findings,and demonstrate clinic...ectal and other types of cancer., PRINCETON, N.J.,...cals announced positive safety and efficacy result...Floxuridine), Liposome,Injection in patients with ...s were presented yesterday in a poster presentatio...
...(CSE: GEN) announced,today pre-clinical data illus...umab) antibody may have broad potential,to treat c...idermal,growth factor receptor). , Recently, mutat...f EGFr have been identified in tumors from lung ca...ctor in the potential success of,EGFr-directed tre...
Other Medicine Technology:Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer,Patients Treated with Therapy Based on Ratiometric Dosing 2Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer,Patients Treated with Therapy Based on Ratiometric Dosing 3
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: